Hypotensive effects of hawthorn for patients with diabetes taking prescription drugs: a randomised controlled trial

Authors: Walker, Ann F.1; Marakis, Georgios1; Simpson, Eleanor2; Hope, Jessica L.3; Robinson, Paul A.4; Hassanein, Mohamed5; Simpson, Hugh C.R.2

Source: British Journal of General Practice, Volume 56, Number 527, June 2006 , pp. 437-443(7)

Publisher: Royal College of General Practitioners

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Background:

Hawthorn (Crataegus laevigata) leaves, flowers and berries are used by herbal practitioners in the UK to treat hypertension in conjunction with prescribed drugs. Small-scale human studies support this approach.

Aim:

To investigate the effects of hawthorn for hypertension in patients with type 2 diabetes taking prescribed drugs.

Design of study:

Randomised controlled trial.

Setting:

General practices in Reading, UK.

Method:

Patients with type 2 diabetes (n = 79) were randomised to daily 1200 mg hawthorn extract (n = 39) or placebo (n = 40) for 16 weeks. At baseline and outcome a wellbeing questionnaire was completed and blood pressure and fasting blood samples taken. A food frequency questionnaire estimated nutrient intake.

Results:

Hypotensive drugs were used by 71% of the study population with a mean intake of 4.4 hypoglycaemic and/or hypotensive drugs. Fat intake was lower and sugar intake higher than recommendations, and low micronutrient intake was prevalent. There was a significant group difference in mean diastolic blood pressure reductions (P = 0.035): the hawthorn group showed greater reductions (baseline: 85.6 mmHg, 95% confidence interval [CI] = 83.3 to 87.8; outcome: 83.0 mmHg, 95% CI = 80.5 to 85.7) than the placebo group (baseline: 84.5 mmHg, 95% CI = 82 to 87; outcome: 85.0 mmHg, 95% CI = 82.2 to 87.8). There was no group difference in systolic blood pressure reduction from baseline (3.6 and 0.8 mmHg for hawthorn and placebo groups, respectively; P = 0.329). Although mean fat intake met current recommendations, mean sugar intake was higher and there were indications of potential multiple micronutrient deficiencies. No herb-drug interaction was found and minor health complaints were reduced from baseline in both groups.

Conclusions:

This is the first randomised controlled trial to demonstrate a hypotensive effect of hawthorn in patients with diabetes taking medication.

Keywords: COMPLEMENTARY THERAPIES; CRATAEGUS; HERB-DRUG INTERACTIONS; HYPERTENSION; PHYTOTHERAPY; PLANT EXTRACTS

Document Type: Research article

Affiliations: 1: Hugh Sinclair Unit of Human Nutrition, School of Food Biosciences, The University of Reading, Reading 2: Diabetes Centre, Royal Berkshire Hospital and Battle Hospital NHS Trust, Reading 3: Department of Applied Statistics, The University of Reading, Reading 4: Department of Clinical Biochemistry, Royal Berkshire Hospital, Reading 5: Renal and Diabetes Centre, Glan Clwyd Hospital, Rhyl

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$31.15 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A